Christopher Ogden

CTMX

Christopher Ogden serves as officer: Chief Financial Officer at CytomX Therapeutics, Inc. (CTMX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

7 trades

$175.0K

Net Position

Net Seller

$175.0K

Companies Traded

CTMX

Active Period

Mar 2023 – Mar 2026

7 total trades

Most Recent

Sell CTMX

Mar 19, 2026 · $124.1K

Christopher Ogden's Insider Trading at CytomX Therapeutics, Inc. (CTMX)

Buys

0 · $0.00

Sells

7 · $175.0K

Total Shares Bought

Total Shares Sold

47,590

CTMX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 19, 2026	Sell	19,323	$6.42	$124.1K	296,948
Jun 13, 2025	Sell	12,255	$2.72	$33.4K	0
Mar 18, 2025	Sell	8,551	$0.60	$5.1K	0
Aug 20, 2024	Sell	1,984	$1.23	$2.4K	0
Mar 19, 2024	Sell	2,971	$2.09	$6.2K	0
Dec 20, 2023	Sell	1,990	$1.38	$2.7K	0
Mar 16, 2023	Sell	516	$1.98	$1.0K	0

Related Insiders

BELVIN MARCIA

SVP, Chief Scientific Officer

CTMXSell · Mar 19, 2026

Yu-Waye Chu

officer: Chief Medical Officer

CTMXSell · Mar 19, 2026

Sean A. McCarthy

director, officer: CEO

CTMXSell · Mar 19, 2026

Explore More Insider Trading Data

CTMX Insider Trading Activity

View all insider trades at CytomX Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity